Proposed acquisition to augment Quintiles Consulting offerings
RESEARCH TRIANGLE PARK, N.C., May 7 /PRNewswire/ -- Quintiles
Transnational Corp. today announced that it has signed an agreement to acquire
Eidetics, a privately held decision-analytics and market research consulting
firm located in Boston as part of its expanding Quintiles Consulting business.
The acquisition of Eidetics will strengthen Quintiles' core consulting
offerings in the areas of product development, commercialization and market
access. Quintiles is expanding its consulting practices to help its
pharmaceutical, biotech and medical device clients navigate the complex
business environment.
"The addition of Eidetics to our Quintiles Consulting business will
further strengthen our ability to provide our clients with distinctive,
data-driven, strategic solutions to their toughest challenges throughout the
product lifecycle," said Jay Norman, President, Quintiles Consulting.
Eidetics has provided research-based market insights and data analytics to
support business decision making in drug development and commercialization for
the past 20 years and counts among its repeat clients 18 of the top 20
pharmaceutical companies.
"We are looking forward to welcoming the Eidetics team to Quintiles
Consulting," Norman said. "They have earned an enviable reputation for strong
research and analytics expertise and outstanding client service. Together, we
will offer industry-leading strategic consulting, powered by life sciences
expertise, operational insights and data analytics."
"We are excited about the opportunity to become part of the Quintiles
organization," said Jim Kirk, Partner, Eidetics. "We believe that joining
Quintiles Consulting will build upon the past success of Eidetics' business,
while providing our clients enhanced clinical, patient and provider data,
greater therapeutic depth and access to global resources."
The transaction is contingent upon the completion of certain conditions of
the purchase agreement.
About Quintiles Consulting
Quintiles Consulting works with pharmaceutical, biotech and medical device
companies to maximize potential and minimize risk from discovery through
development and commercialization by providing expert strategic, operational
and technical advice. Building on the global reach and expertise of Quintiles
Transnational, Quintiles Consulting practice areas include Product Development
and Commercialization, Regulatory and Quality, and Market Access. Quintiles
Consulting have full-time consultants based across the U.S. and Europe to
serve its global clients. For more information, please visit
www.quintiles.com/consulting .
About Quintiles
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, strategic partnering and commercialization for the
pharmaceutical, biotechnology and medical device industries. With more than
20,000 employees and offices in more than 50 countries, it is focused on
providing customer-centric solutions that are the gold standard of the
industry. For more information, please visit the company's Web site at
www.quintiles.com .
SOURCE Quintiles Transnational Corp.
Mari Mansfield, +1-919-998-2639, +1-919-259-3298 (mobile),
mari.mansfield@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, greg.connors@quintiles.com, both of Quintiles Transnational
Corp.
